CR8590A - Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos - Google Patents

Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos

Info

Publication number: CR8590A
Authority: CR; Costa Rica
Prior art keywords: protected; methods; morphinots; morphinot; dienol
Prior art date: 2004-02-06

Application number

CR8590A

Other languages

English (en)

Spanish (es)

Inventor

Stumpf Coverty Andreas

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-06

Filing date

2006-09-01

Publication date

2007-07-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34860329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-09-01 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2007-07-19 Publication of CR8590A publication Critical patent/CR8590A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)

CR8590A 2004-02-06 2006-09-01 Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos CR8590A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US54271104P	2004-02-06	2004-02-06

Publications (1)

Publication Number	Publication Date
CR8590A true CR8590A (es)	2007-07-19

Family

ID=34860329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CR8590A CR8590A (es)	2004-02-06	2006-09-01	Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos

Country Status (33)

Country	Link
US (6)	US8003793B2 (uk)
EP (3)	EP1711502B1 (uk)
JP (1)	JP4963968B2 (uk)
KR (4)	KR101011460B1 (uk)
CN (1)	CN1918168B (uk)
AP (1)	AP2006003716A0 (uk)
AT (2)	ATE451374T1 (uk)
AU (1)	AU2005212258B2 (uk)
BR (1)	BRPI0506607B8 (uk)
CA (2)	CA2555215C (uk)
CR (1)	CR8590A (uk)
CY (2)	CY1108506T1 (uk)
DE (2)	DE602005018265D1 (uk)
DK (2)	DK1864987T3 (uk)
EA (2)	EA016062B1 (uk)
EC (1)	ECSP066824A (uk)
ES (2)	ES2313299T3 (uk)
GE (1)	GEP20084454B (uk)
HR (2)	HRP20080618T3 (uk)
IL (2)	IL177281A (uk)
MA (1)	MA28346A1 (uk)
MX (1)	MXPA06008931A (uk)
NO (2)	NO20063989L (uk)
NZ (2)	NZ548786A (uk)
PL (2)	PL1864987T3 (uk)
PT (2)	PT1864987E (uk)
RS (2)	RS51317B (uk)
SG (1)	SG150500A1 (uk)
SI (2)	SI1711502T1 (uk)
TN (1)	TNSN06248A1 (uk)
UA (2)	UA88646C2 (uk)
WO (1)	WO2005077957A2 (uk)
ZA (1)	ZA200606252B (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2555215C (en)	2004-02-06	2013-05-21	Euro-Celtique S.A.	Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
ATE517869T1 (de) *	2006-09-20	2011-08-15	Mallinckrodt Inc	Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
US9040726B2 (en)	2007-03-06	2015-05-26	Mallinckrodt Llc	Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
CA2707757C (en) *	2007-03-06	2017-01-03	Peter X. Wang	Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
ES2549904T3 (es) *	2008-05-27	2015-11-03	Mallinckrodt Llc	Procesos y compuestos para la preparación de normorfinanos
EP2331508B1 (en) *	2008-09-03	2014-11-12	Mallinckrodt LLC	Substituted berbines and processes for their synthesis
NZ603173A (en)	2010-05-10	2014-10-31	Euro Celtique Sa	Manufacturing of active-free granules and tablets comprising the same
CN103002881B (zh)	2010-05-10	2015-09-02	欧洲凯尔特公司	载有活性剂的颗粒与额外活性剂的组合
WO2011141488A2 (en)	2010-05-10	2011-11-17	Euro-Celtique S.A.	Pharmaceutical compositions comprising hydromorphone and naloxone
WO2015071380A1 (en)	2013-11-13	2015-05-21	Euro-Celtique S.A.	Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
EP3357898B1 (en) *	2015-09-30	2020-11-25	FUJIFILM Wako Pure Chemical Corporation	Method for producing organic compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2654756A (en)	1949-10-20	1953-10-06	Mallinckrodt Chemical Works	Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
DE902257C (de)	1951-07-17	1954-01-21	Knoll Ag	Verfahren zur Herstellung von Acylderivaten der Enolform des Codeinons
GB1495271A (en)	1974-04-10	1977-12-14	Macfarlan Smith Ltd	Dehydrohalogenation of codeinone derivatives
US4472253A (en)	1981-08-17	1984-09-18	The Florida Board Of Regents On Behalf Of The Florida State University	Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative
US5112975A (en)	1984-03-27	1992-05-12	Mallinckrodt Specialty Chemicals Company	Preparation of noroxymorphone from morphine
SE9003665D0 (sv)	1990-11-16	1990-11-16	Kabivitrum Ab	Morphine prodrugs
GB9116909D0 (en)	1991-08-06	1991-09-18	Salford Ultrafine Chem & Res	Morphine derivatives
US5821374A (en)	1995-11-21	1998-10-13	Hoffmann-La Roche Inc.	Process for the oxidation of alcohols
US5869669A (en)	1996-07-26	1999-02-09	Penick Corporation	Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) *	1997-06-30	1997-09-03	Johnson Matthey Plc	Preparation of opiates
US6177567B1 (en)	1999-10-15	2001-01-23	Boehringer Ingelheim Chemicals, Inc.	Method for preparing oxycodone
US6596877B2 (en)	2001-10-17	2003-07-22	Novartis Ag	Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
CA2555215C (en)	2004-02-06	2013-05-21	Euro-Celtique S.A.	Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates

2005
- 2005-02-04 CA CA2555215A patent/CA2555215C/en not_active Expired - Lifetime
- 2005-02-04 EA EA200801811A patent/EA016062B1/ru not_active IP Right Cessation
- 2005-02-04 ES ES05712726T patent/ES2313299T3/es not_active Expired - Lifetime
- 2005-02-04 SI SI200530468T patent/SI1711502T1/sl unknown
- 2005-02-04 DE DE602005018265T patent/DE602005018265D1/de not_active Expired - Lifetime
- 2005-02-04 AT AT07014411T patent/ATE451374T1/de active
- 2005-02-04 AP AP2006003716A patent/AP2006003716A0/xx unknown
- 2005-02-04 AU AU2005212258A patent/AU2005212258B2/en not_active Expired
- 2005-02-04 UA UAA200704105A patent/UA88646C2/uk unknown
- 2005-02-04 PT PT07014411T patent/PT1864987E/pt unknown
- 2005-02-04 HR HR20080618T patent/HRP20080618T3/xx unknown
- 2005-02-04 EP EP05712726A patent/EP1711502B1/en not_active Expired - Lifetime
- 2005-02-04 CA CA2808199A patent/CA2808199C/en not_active Expired - Lifetime
- 2005-02-04 SG SG200900838-4A patent/SG150500A1/en unknown
- 2005-02-04 CN CN2005800040830A patent/CN1918168B/zh not_active Expired - Lifetime
- 2005-02-04 PT PT05712726T patent/PT1711502E/pt unknown
- 2005-02-04 NZ NZ548786A patent/NZ548786A/en not_active IP Right Cessation
- 2005-02-04 ES ES07014411T patent/ES2338054T3/es not_active Expired - Lifetime
- 2005-02-04 PL PL07014411T patent/PL1864987T3/pl unknown
- 2005-02-04 EP EP07014411A patent/EP1864987B1/en not_active Expired - Lifetime
- 2005-02-04 DK DK07014411.8T patent/DK1864987T3/da active
- 2005-02-04 MX MXPA06008931A patent/MXPA06008931A/es active IP Right Grant
- 2005-02-04 SI SI200530925T patent/SI1864987T1/sl unknown
- 2005-02-04 RS RSP-2010/0064A patent/RS51317B/sr unknown
- 2005-02-04 BR BRPI0506607A patent/BRPI0506607B8/pt not_active IP Right Cessation
- 2005-02-04 NZ NZ565355A patent/NZ565355A/en not_active IP Right Cessation
- 2005-02-04 KR KR1020097016500A patent/KR101011460B1/ko not_active Expired - Lifetime
- 2005-02-04 AT AT05712726T patent/ATE406372T1/de active
- 2005-02-04 GE GEAP20059608A patent/GEP20084454B/en unknown
- 2005-02-04 US US10/588,637 patent/US8003793B2/en active Active
- 2005-02-04 WO PCT/US2005/003390 patent/WO2005077957A2/en not_active Ceased
- 2005-02-04 DK DK05712726T patent/DK1711502T3/da active
- 2005-02-04 DE DE602005009321T patent/DE602005009321D1/de not_active Expired - Lifetime
- 2005-02-04 KR KR1020077025207A patent/KR20070108956A/ko not_active Ceased
- 2005-02-04 EP EP09015220A patent/EP2194059A3/en not_active Withdrawn
- 2005-02-04 RS RSP-2008/0553A patent/RS50663B/sr unknown
- 2005-02-04 KR KR1020077025206A patent/KR100921695B1/ko not_active Expired - Lifetime
- 2005-02-04 PL PL05712726T patent/PL1711502T3/pl unknown
- 2005-02-04 JP JP2006552236A patent/JP4963968B2/ja not_active Expired - Lifetime
- 2005-02-04 EA EA200601394A patent/EA012905B1/ru not_active IP Right Cessation
- 2005-04-02 UA UAA200609622A patent/UA87833C2/uk unknown
2006
- 2006-07-28 ZA ZA200606252A patent/ZA200606252B/en unknown
- 2006-08-03 IL IL177281A patent/IL177281A/en active IP Right Grant
- 2006-08-04 MA MA29240A patent/MA28346A1/fr unknown
- 2006-08-04 TN TNP2006000248A patent/TNSN06248A1/fr unknown
- 2006-09-01 CR CR8590A patent/CR8590A/es unknown
- 2006-09-05 EC EC2006006824A patent/ECSP066824A/es unknown
- 2006-09-05 KR KR1020067018113A patent/KR100921696B1/ko not_active Expired - Lifetime
- 2006-09-06 NO NO20063989A patent/NO20063989L/no not_active Application Discontinuation
2008
- 2008-11-12 CY CY20081101295T patent/CY1108506T1/el unknown
2010
- 2010-02-25 CY CY20101100178T patent/CY1109838T1/el unknown
- 2010-03-05 HR HR20100123T patent/HRP20100123T1/hr unknown
- 2010-05-06 IL IL205596A patent/IL205596A/en active IP Right Grant
2011
- 2011-07-22 US US13/189,228 patent/US8198444B2/en not_active Expired - Lifetime
2012
- 2012-05-15 US US13/472,227 patent/US8685996B2/en not_active Expired - Lifetime
2014
- 2014-02-24 US US14/188,430 patent/US8975257B2/en not_active Expired - Lifetime
2015
- 2015-03-02 NO NO20150276A patent/NO339083B1/no unknown
- 2015-03-03 US US14/637,129 patent/US9670218B2/en not_active Expired - Fee Related
2017
- 2017-05-04 US US15/587,118 patent/US20170233400A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR100921696B1 (ko)	2009-10-15
SI1711502T1 (sl)	2009-02-28
US20170233400A1 (en)	2017-08-17
IL205596A (en)	2011-11-30
MA28346A1 (fr)	2006-12-01
US20080146804A1 (en)	2008-06-19
EP2194059A2 (en)	2010-06-09
CA2555215C (en)	2013-05-21
EP1864987A3 (en)	2008-02-20
EA200601394A1 (ru)	2006-12-29
AP2006003716A0 (en)	2006-08-31
BRPI0506607B1 (pt)	2018-01-16
AU2005212258A1 (en)	2005-08-25
EP1864987A2 (en)	2007-12-12
JP4963968B2 (ja)	2012-06-27
CY1108506T1 (el)	2014-04-09
RS51317B (sr)	2010-12-31
NZ565355A (en)	2008-09-26
US20150239898A1 (en)	2015-08-27
RS50663B (sr)	2010-06-30
BRPI0506607B8 (pt)	2021-05-25
CN1918168A (zh)	2007-02-21
US8003793B2 (en)	2011-08-23
DK1864987T3 (da)	2010-04-12
UA87833C2 (uk)	2009-08-25
US20140171643A1 (en)	2014-06-19
CA2808199A1 (en)	2005-08-25
WO2005077957A3 (en)	2006-05-04
NO339083B1 (no)	2016-11-14
ATE406372T1 (de)	2008-09-15
CY1109838T1 (el)	2014-09-10
AU2005212258B2 (en)	2008-05-22
DE602005009321D1 (de)	2008-10-09
KR100921695B1 (ko)	2009-10-15
ES2313299T3 (es)	2009-03-01
HK1119160A1 (en)	2009-02-27
JP2007520563A (ja)	2007-07-26
TNSN06248A1 (fr)	2007-12-03
US8198444B2 (en)	2012-06-12
SI1864987T1 (sl)	2010-04-30
SG150500A1 (en)	2009-03-30
IL177281A0 (en)	2006-12-10
WO2005077957A2 (en)	2005-08-25
KR20070117701A (ko)	2007-12-12
CA2808199C (en)	2015-10-27
EA012905B1 (ru)	2010-02-26
CA2555215A1 (en)	2005-08-25
ATE451374T1 (de)	2009-12-15
EP1711502B1 (en)	2008-08-27
US20120022259A1 (en)	2012-01-26
CN1918168B (zh)	2011-04-27
EA016062B1 (ru)	2012-01-30
US9670218B2 (en)	2017-06-06
ES2338054T3 (es)	2010-05-03
DK1711502T3 (da)	2008-12-01
NO20150276L (no)	2006-10-31
EP2194059A3 (en)	2010-09-22
ECSP066824A (es)	2006-12-29
EA200801811A1 (ru)	2008-12-30
US8975257B2 (en)	2015-03-10
BRPI0506607A (pt)	2007-05-02
US20120225902A1 (en)	2012-09-06
PL1864987T3 (pl)	2010-05-31
IL177281A (en)	2012-02-29
ZA200606252B (en)	2007-11-28
PL1711502T3 (pl)	2009-02-27
NO20063989L (no)	2006-10-31
DE602005018265D1 (de)	2010-01-21
GEP20084454B (en)	2008-08-10
HK1103071A1 (en)	2007-12-14
KR20090089486A (ko)	2009-08-21
UA88646C2 (uk)	2009-11-10
KR20070108956A (ko)	2007-11-13
MXPA06008931A (es)	2007-01-26
NZ548786A (en)	2008-08-29
PT1864987E (pt)	2010-03-09
PT1711502E (pt)	2008-11-20
KR101011460B1 (ko)	2011-01-28
HRP20080618T3 (hr)	2009-01-31
HRP20100123T1 (hr)	2010-04-30
KR20070026401A (ko)	2007-03-08
US8685996B2 (en)	2014-04-01
EP1711502A2 (en)	2006-10-18
EP1864987B1 (en)	2009-12-09

Publication	Publication Date	Title
UY33981A (es)	2013-10-31	?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?.
CR11618A (es)	2011-01-31	Inhibidores macrocíclicos de serina proteasa
CY1118332T1 (el)	2017-06-28	Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξamιδο-πυριδιno βενζοϊκων οξεων
HN2006000668A (es)	2010-09-17	Compuestos de quinolina heteroaromaticos
CL2012002464A1 (es)	2013-01-11	Proceso para la preparación de compuestos pesticidas que contienen un grupo tio-triazolo, que comprende hacer reaccionar un compuesto triazolo con un reactivo de grignard; compuestos pesticidas que contienen un grupo tio-triazolo; y su uso.
UY29479A1 (es)	2006-11-30	Inhibidores de adn-pk
CL2008000322A1 (es)	2008-09-05	Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.
CY1112722T1 (el)	2016-02-10	Μυκητοκτονες συνθεσεις
ATE479687T1 (de)	2010-09-15	Kinaseinhibitoren
CL2008003790A1 (es)	2010-02-05	Metodo para purificar anticuerpo cd20 de una mezcla que comprende cristalizar el anticuerpo cd20 y recuperar el anticuerpo cd20 de la mezcla.
CL2008001693A1 (es)	2009-03-06	Compuestos derivados de piridil-pirimidinil-amino; composicion fungicida que comprende a dichos compuestos; y metodo para controlar los hongos fitopatogenos de los cultivos; y compuesto intermediario.
CO6382079A2 (es)	2012-02-15	Composiciones insecticidas estables a base de sulfoximina
MX2009005934A (es)	2009-06-17	Compuestos organicos.
ECSP11011307A (es)	2011-10-31	Comprimidos para terapia de combinacion
ECSP077984A (es)	2008-01-23	Formulacion de un inhibidor de agregacion de plaquetas de tienopiridina
CR10156A (es)	2008-10-03	Metodos para preparar alcoholes sulfonamida sustituidos e intermediarios de estos
GT200800251A (es)	2009-05-04	Nitrilos espirociclicos como inhibidores de proteasa
ECSP11011494A (es)	2011-12-30	Preparación de solido
CR8590A (es)	2007-07-19	Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos
EA200702464A1 (ru)	2008-04-28	Способы получения фенольных 4-бифенилилазетидин-2-онов
ATE475648T1 (de)	2010-08-15	Piperidin- oder piperazin-substituierte tetrahydronaphthalin-1-carbonsäureverbindungen, die mtp inhibieren
CR20120117A (es)	2012-07-06	Métodos para la propagación vegetativa de gramíneas
BRPI0817010A2 (pt)	2015-03-24	Processo de preparação de um composto p-hidroximandélico eventualmente substituído e derivado e de um aldeído 4-hidroxiaromático.
ATE417849T1 (de)	2009-01-15	Pyrazoloä4,3-düpyrimidine
CL2012001248A1 (es)	2012-09-28	Compuestos de amidoacetonitrilo que tiene actividad pesticida; uso de dicho compuesto para el control de parasitos en animales de sangre caliente.